Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Biotron ( (AU:BIT) ) has issued an announcement.
Biotron Limited has announced the quotation of 33,333,333 ordinary fully paid securities on the Australian Securities Exchange (ASX), effective December 10, 2025. This move is part of a previously announced transaction and is expected to enhance Biotron’s market presence and provide additional capital to support its ongoing research and development efforts.
More about Biotron
Biotron Limited operates in the biotechnology industry, focusing on the development of novel antiviral therapies. The company is engaged in creating innovative solutions to address significant unmet needs in the treatment of viral infections.
YTD Price Performance: -38.89%
Technical Sentiment Signal: Sell
Current Market Cap: A$4.98M
For an in-depth examination of BIT stock, go to TipRanks’ Overview page.